Receta Pharmaceuticals India Private Limited logo

Receta Pharmaceuticals India Private Limited

Pharmaceutical company with anti-infective, pain management, and nutraceutical products.
2011 | Mumbai, Maharashtra (India) | Active

Last Updated:

December 05, 2024
HomeCompanyReceta Pharmaceuticals India Private Limited

Who are the key members and board of directors at Receta Pharmaceuticals India?

Board Members(2)

NameDesignationAppointment DateStatus
Uday Dole In Director 28-Nov-2011Current
Prashant Kitlekar In Director 08-Jun-2024Current

Financial Performance of Receta Pharmaceuticals India.

Receta Pharmaceuticals India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 70.61% decrease. The company also saw a substantial improvement in profitability, with a 351.06% increase in profit. The company's net worth dipped by a decrease of 7.04%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-70.61%
Revenue from Operations
-69.82%
Total Assets
-56.33%
Profit or Loss
351.06%
Net Worth
-7.04%
EBITDA
498.17%

Related Corporates (Common Directorship)

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Receta Pharmaceuticals India?

Unlock and access historical data on people associated with Receta Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Receta Pharmaceuticals India

Recent activity within the organization

  • Director Appointment

    Prashant Krishna Kitlekar was appointed as a Director was appointed as a Director on 08 Jun 2024 & has been associated with this company since 6 months 16 days .

    08 Jun 2024

  • Annual General Meeting

    Receta Pharmaceuticals India Private Limited last Annual general meeting of members was held on 06 Sep 2023 as per latest MCA records.

    06 Sep 2023

  • Balance Sheet

    Receta Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

    31 Mar 2023

  • Director Appointment

    Uday Madhukar Dole was appointed as a Director was appointed as a Director on 28 Nov 2011 & has been associated with this company since 13 years 25 days .

    28 Nov 2011

  • Company Incorporation

    Receta Pharmaceuticals India Private Limited was registered on 28 Nov 2011 with Roc Mumbai & aged 13 years 25 days as per MCA records.

    28 Nov 2011

Frequently asked questions

  • Receta Pharmaceuticals India Private Limited was incorporated on 28 Nov 2011.

  • The authorized share capital of Receta Pharmaceuticals India Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Receta Pharmaceuticals India Private Limited.

    • Prashant Krishna Kitlekar
    • Uday Madhukar Dole
  • As per Ministry of Corporate Affairs (Mca), the registered address of Receta Pharmaceuticals India Private Limited is 6 Madhu Industrial Estate Pandurang Buhdkar Marg Lower Parel (West), India, Mumbai, Maharashtra, 400013.

  • The corporate identification number (CIN) of Receta Pharmaceuticals India Private Limited is U51101MH2011PTC224421 and the company number is 224421 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Receta Pharmaceuticals India Private Limited is https://www.recetapharma.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Receta Pharmaceuticals India Private Limited has fallen by -70.61%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Receta Pharmaceuticals India Private Limited has experienced an downturn of -7.04%.

  • The most recent Balance Sheet for Receta Pharmaceuticals India Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development